
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B808926007933AB80800583106DF.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="eclinm">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="eClinicalMedicine">
<meta name="citation_title" content="Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis">
<meta name="citation_author" content="Jie Wang">
<meta name="citation_author_institution" content="Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_author_institution" content="College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Hongyu Chen">
<meta name="citation_author_institution" content="West China School of Public Health, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_author" content="Zihuan Tang">
<meta name="citation_author_institution" content="West China School of Public Health, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_author" content="Jinquan Zhang">
<meta name="citation_author_institution" content="Division of Informatics, Imaging, and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK">
<meta name="citation_author" content="Yuanwei Xu">
<meta name="citation_author_institution" content="Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_author" content="Ke Wan">
<meta name="citation_author_institution" content="Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_author" content="Kifah Hussain">
<meta name="citation_author_institution" content="Department of Cardiology, NorthShore University Health Systems, Evanston, Illinois, USA">
<meta name="citation_author" content="Georgios V Gkoutos">
<meta name="citation_author_institution" content="College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK">
<meta name="citation_author_institution" content="Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK">
<meta name="citation_author_institution" content="Health Data Research UK (HDR), Midlands Site, UK">
<meta name="citation_author_institution" content="Centre for Health Data Science, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Yuchi Han">
<meta name="citation_author_institution" content="Cardiovascular Division, Wexner Medical Centre, The Ohio State University, USA">
<meta name="citation_author" content="Yucheng Chen">
<meta name="citation_author_institution" content="Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_author_institution" content="Centre of Rare Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China">
<meta name="citation_publication_date" content="2023 Aug 24">
<meta name="citation_volume" content="63">
<meta name="citation_firstpage" content="102172">
<meta name="citation_doi" content="10.1016/j.eclinm.2023.102172">
<meta name="citation_pmid" content="37662524">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/pdf/main.pdf">
<meta name="description" content="Previous studies have reported that tafamidis treatment was associated with better outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with those without tafamidis treatment. Therefore, we aimed to systematically assess ...">
<meta name="og:title" content="Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Previous studies have reported that tafamidis treatment was associated with better outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with those without tafamidis treatment. Therefore, we aimed to systematically assess ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="10474377">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1016/j.eclinm.2023.102172"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/main.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC10474377%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/10474377/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/10474377/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-eclinm.jpg" alt="eClinicalMedicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to eClinicalMedicine" title="Link to eClinicalMedicine" shape="default" href="https://www.thelancet.com/journals/eclinm/home" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">eClinicalMedicine</button></div>. 2023 Aug 24;63:102172. doi: <a href="https://doi.org/10.1016/j.eclinm.2023.102172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/j.eclinm.2023.102172</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22eClinicalMedicine%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22eClinicalMedicine%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22eClinicalMedicine%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22eClinicalMedicine%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Jie Wang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Jie Wang</span></h3>
<div class="p">
<sup>a</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">
<sup>b</sup>College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jie Wang</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>l</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Hongyu Chen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Hongyu Chen</span></h3>
<div class="p">
<sup>c</sup>West China School of Public Health, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hongyu Chen</span></a>
</div>
</div>
<sup>c,</sup><sup>l</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Zihuan Tang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Zihuan Tang</span></h3>
<div class="p">
<sup>c</sup>West China School of Public Health, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zihuan Tang</span></a>
</div>
</div>
<sup>c,</sup><sup>l</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jinquan Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jinquan Zhang</span></h3>
<div class="p">
<sup>d</sup>Division of Informatics, Imaging, and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinquan Zhang</span></a>
</div>
</div>
<sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Yuanwei Xu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Yuanwei Xu</span></h3>
<div class="p">
<sup>a</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuanwei Xu</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ke Wan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ke Wan</span></h3>
<div class="p">
<sup>e</sup>Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wan%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Ke Wan</span></a>
</div>
</div>
<sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hussain%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Kifah Hussain</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Kifah Hussain</span></h3>
<div class="p">
<sup>f</sup>Department of Cardiology, NorthShore University Health Systems, Evanston, Illinois, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hussain%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kifah Hussain</span></a>
</div>
</div>
<sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gkoutos%20GV%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Georgios V Gkoutos</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Georgios V Gkoutos</span></h3>
<div class="p">
<sup>b</sup>College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK</div>
<div class="p">
<sup>g</sup>Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK</div>
<div class="p">
<sup>h</sup>Health Data Research UK (HDR), Midlands Site, UK</div>
<div class="p">
<sup>i</sup>Centre for Health Data Science, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gkoutos%20GV%22%5BAuthor%5D" class="usa-link"><span class="name western">Georgios V Gkoutos</span></a>
</div>
</div>
<sup>b,</sup><sup>g,</sup><sup>h,</sup><sup>i</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Yuchi Han</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Yuchi Han</span></h3>
<div class="p">
<sup>j</sup>Cardiovascular Division, Wexner Medical Centre, The Ohio State University, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Han%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuchi Han</span></a>
</div>
</div>
<sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Yucheng Chen</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Yucheng Chen</span></h3>
<div class="p">
<sup>a</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">
<sup>k</sup>Centre of Rare Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yucheng Chen</span></a>
</div>
</div>
<sup>a,</sup><sup>k,</sup><sup>∗</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>a</sup>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div id="aff2">
<sup>b</sup>College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK</div>
<div id="aff3">
<sup>c</sup>West China School of Public Health, Sichuan University, Chengdu, Sichuan, China</div>
<div id="aff4">
<sup>d</sup>Division of Informatics, Imaging, and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK</div>
<div id="aff5">
<sup>e</sup>Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div id="aff6">
<sup>f</sup>Department of Cardiology, NorthShore University Health Systems, Evanston, Illinois, USA</div>
<div id="aff7">
<sup>g</sup>Institute of Translational Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK</div>
<div id="aff8">
<sup>h</sup>Health Data Research UK (HDR), Midlands Site, UK</div>
<div id="aff9">
<sup>i</sup>Centre for Health Data Science, University of Birmingham, Birmingham, UK</div>
<div id="aff10">
<sup>j</sup>Cardiovascular Division, Wexner Medical Centre, The Ohio State University, USA</div>
<div id="aff11">
<sup>k</sup>Centre of Rare Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>∗</sup><p class="display-inline">Corresponding author. Department of Cardiology, West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, China. <span>Chenyucheng2003@126.com</span><span>Chenyucheng2003@163.com</span></p>
</div>
<div class="fn" id="fn1">
<sup>l</sup><p class="display-inline" id="ntpara0010">These authors contributed equally to this work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2023 Apr 5; Revised 2023 Aug 5; Accepted 2023 Aug 8; Collection date 2023 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2023 The Author(s)</div>
<p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC10474377  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37662524/" class="usa-link">37662524</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abs0010"><h2>Summary</h2>
<section id="sec1_pmc"><h3 class="pmc_sec_title">Background</h3>
<p>Previous studies have reported that tafamidis treatment was associated with better outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared with those without tafamidis treatment. Therefore, we aimed to systematically assess the association of tafamidis treatment with outcomes in patients with ATTR-CM.</p></section><section id="sec2_pmc"><h3 class="pmc_sec_title">Methods</h3>
<p>The protocol for this systematic review and meta-analysis was registered in the PROSPERO (CRD42022381985). Pubmed, Ovid Embase, Scopus, Cochrane Library, and Web of Science were interrogated to identify studies that evaluated the impact of tafamidis on prognosis in ATTR-CM, from January 1, 2000 to June 1, 2023. A random-effects model was used to determine the pooled risk ratio (RR) for the adverse endpoints. In addition, the main outcomes included all-cause death or heart transplantation, the composite endpoints included all-cause death, heart transplantation, cardiac-assist device implantation, heart failure exacerbations, and hospitalization.</p></section><section id="sec3_pmc"><h3 class="pmc_sec_title">Findings</h3>
<p>Fifteen studies comprising 2765 patients (mean age 75.9 ± 9.3 years; 83.7% male) with a mean follow-up duration of 18.7 ± 17.1 months were included in the meta-analysis. There was a decrease in left ventricular ejection fraction (LVEF) (standard mean differences (SMD: −0.17; 95% confidence interval (CI), −0.31 to −0.03; <em>P</em> = 0.02) but were no significant differences in intraventricular septum (IVS) thickness or global longitudinal strain (GLS) after tafamidis treatment. However, subgroup analysis showed no significant deterioration in LVEF in the patients with wild-type ATTR after tafamidis treatment (SMD: −0.11; 95% CI, −0.34 to 0.12, <em>P</em> = 0.34). In addition, the group with tafamidis treatment had a decreased risk for all-cause death or heart transplantation compared to patients without treatment (the pooled RR, 0.44; 95% CI, 0.31–0.65; <em>P</em> &lt; 0.01). Subgroup analysis showed that there was no significant difference of tafamidis on the outcomes in patients with wild-type or hereditary ATTR (RR, 0.44; 95% CI, 0.27–0.73 <em>versus</em> 0.21, 95% CI, 0.11–0.40, <em>P</em> = 0.08). Furthermore, tafamidis treatment was associated with a lower risk of the composite endpoint (RR, 0.57; 95% CI, 0.42–0.77; <em>P</em> &lt; 0.01).</p></section><section id="sec4_pmc"><h3 class="pmc_sec_title">Interpretation</h3>
<p>Our findings suggested that there was no significant deterioration in LVEF in the patients with wild-type ATTR after tafamidis treatment. In addition, tafamidis treatment was associated with a low risk of all-cause death and adverse cardiovascular events.</p></section><section id="sec5_pmc"><h3 class="pmc_sec_title">Funding</h3>
<p>This work was supported by grants from the Natural Science Foundation of Sichuan Province [Grant Number: 23NSFSC4589] and the National Natural Science Foundation of China [Grant Number: 82202248].</p></section><section id="kwrds0010" class="kwd-group"><p><strong>Keywords:</strong> Tafamidis, Transthyretin amyloid cardiomyopathy, ATTR, Prognosis</p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="dtbox1"><h2 class="obj_head">Research in context.</h2>
<section id="dtbox1sec1"><h3 class="pmc_sec_title">Evidence before this study</h3>
<p id="p0015">We sought studies across Pubmed, Ovid Embase, Scopus, Cochrane Library, and Web of Science between January 1, 2000 and June 1, 2023. We included observational cohort studies, randomized controlled trials, and early-phase clinical trials published in peer-reviewed journals accompanied by a complete analysis of the impact of tafamidis on prognosis in patients with ATTR-CM. Duplicated studies were excluded using Endnote version X9 (Clarivate Analytics). The studies with a mean/median follow-up time greater than 6 months and published in English were considered. The editorials, reviews, commentaries, conference abstracts, and case reports were excluded. The quality of included studies was independently assessed using the Cochrane risk of bias tool for randomized controlled trials and the Newcastle-Ottawa Scale for observational studies.</p></section><section id="dtbox1sec2"><h3 class="pmc_sec_title">Added value of this study</h3>
<p id="p0020">There was no significant deterioration in LVEF in the patients with wild-type ATTR after tafamidis treatment and tafamidis treatment is associated with a low risk of all-cause death, heart transplant, heart assist device implantation, heart failure exacerbations and hospitalization in patients with ATTR-CM.</p></section><section id="dtbox1sec3"><h3 class="pmc_sec_title">Implications of all the available evidence</h3>
<p id="p0025">Our systematic meta-analysis highlights the survival benefit of tafamidis treatment, which strengthens the evidence for recommendations for the treatment of patients with ATTR-CM. Further research, encompassing larger sample sizes and long-term follow-up, is warranted to evaluate the efficacy of tafamidis in the treatment of ATTR.</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="p0030">Transthyretin amyloid cardiomyopathy (ATTR-CM) is a severe disease characterized by an accumulation of amyloid fibrils composed of misfolded transthyretin protein in the heart.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a> The prevalence of ATTR-CM was varied in certain patient cohorts, such as 16% in patients with severe calcific aortic stenosis undergoing transcatheter aortic valve implantation (TAVI),<a href="#bib2" class="usa-link" aria-describedby="bib2"><sup>2</sup></a> 13% in patients with heart failure (HF) with preserved ejection fraction (HFpEF) and with left ventricular hypertrophy (LVH).<a href="#bib3" class="usa-link" aria-describedby="bib3"><sup>3</sup></a> ATTR-CM is a rapidly progressive disorder with a median survival of 2–6 years.<a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a> Early diagnosis of patients with ATTR-CM and the timely initiation of therapy is important.</p>
<p id="p0035">Traditional therapies, such as beta-blockers or angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB) for symptomatic relief, cannot reverse the underlying cause of ATTR-CM. Recent evidence suggests that the treatment with tafamidis is beneficial in patients with ATTR-CM.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a><sup>,</sup><a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a> Tafamidis is a transthyretin stabilizer that can potently occupy thyroxine-binding sites and keep the tetrameric structure of the transthyretin protein from dissociating into intermediates transthyretin protein with high specificity.<a href="#bib5" class="usa-link" aria-describedby="bib5"><sup>5</sup></a> In the ATTR-ACT trial, tafamidis was reported to be associated with improved survival in patients with ATTR-CM,<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> similar to other observational studies.<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>, <a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>, <a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>, <a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib14" class="usa-link" aria-describedby="bib14">14</a> Moreover, other studies have reported that tafamidis delays structural and functional changes in the left ventricle.<a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a><sup>,</sup><a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a> Nevertheless, changes in the left ventricle, following tafamidis treatment, vary within these studies and its efficacy is limited by small sample sizes, low number of events, and short follow-up periods. Up to date, there were systematic reviews on the efficacy of tafamidis in patients with ATTR-CM but no meta-analysis had been conducted.</p>
<p id="p0040">Thus, we conducted a systematic review and random-effects meta-analysis for estimating the efficacy of tafamidis in patients with ATTR-CM.</p></section><section id="sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">Search strategy and selection criteria</h3>
<p id="p0045">A systematic interrogation across Pubmed, Ovid Embase, Scopus, Cochrane Library and Web of Science was conducted by two independent reviewers (HYC and ZHT) to identify publications of studies that assessed the efficacy of tafamidis on outcomes in patients with ATTR-CM between January 1, 2000 and June 1, 2023. The detailed search protocol is provided in the <a href="#appsec1" class="usa-link">Supplemental Material</a>.</p>
<p id="p0050">A systematic review and meta-analysis of studies relating to the treatment of ATTR-CM patients with tafamidis was performed in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and was previously registered with PROSPERO (CRD42022381985).<a href="#bib17" class="usa-link" aria-describedby="bib17"><sup>17</sup></a> The ethical approval and informed consent of participants were waived for this study type. The inclusion criteria were as follows: 1) observational cohort studies (both retrospective and prospective) or randomized controlled trials; 2) early-phase clinical trials published in peer-reviewed journals accompanied by complete analysis; 3) studies examining the impact of tafamidis on prognosis in patients with ATTR-CM; 4) studies with a mean/median follow-up time greater than 6 months; and 5) studies published in English. The exclusion criteria included editorials, reviews, commentaries, conference abstracts, and case reports.</p></section><section id="sec2.2"><h3 class="pmc_sec_title">Data analysis</h3>
<p id="p0055">Two independent reviewers (HYC and ZHT) screened publication titles and abstracts, based on the inclusion and exclusion criteria, and then further confirmed whether the full text met the inclusion criteria. Duplicated studies were excluded using Endnote version X9 (Clarivate Analytics). Any discrepancy was resolved by a third reviewer (JW). Eligible study data were extracted by the two reviewers (HYC and ZHT) using a predetermined data collection table. Study characteristics including the first author, year of publication, study design, sample size, patient population, and study duration, as well as patient characteristics including age, sex, NYHA class, ATTR type, race, baseline and outcome measures, were extracted. The primary endpoint was defined as all-cause death or heart transplantation, while the composite endpoints included all-cause death, heart transplantation, cardiac-assist device implantation, heart failure exacerbations and hospitalization. The differences in left ventricular ejection fractions (LVEF), intraventricular septum (IVS) thickness, and global longitudinal strain (GLS) on echocardiograms or cardiovascular magnetic resonance (CMR) imaging between the before and after tafamidis treatment were extracted. For the study from Bezard et al.,<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a> the numbers of endpoints were extracted by survival curves using IPDfromKM.<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> In addition, we conducted propensity score matching (PSM) in two studies<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>,</sup><a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> that underwent PSM for inclusion to control baseline differences. Furthermore, four studies,<a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>, <a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>, <a href="#bib21" class="usa-link" aria-describedby="bib21">21</a>, <a href="#bib22" class="usa-link" aria-describedby="bib22">22</a> provided as median (range), were converted into mean ± SD for pooled SMDs calculation.</p>
<p id="p0060">The quality of included studies was independently assessed by two reviewers (HYC and ZHT) using the Cochrane risk of bias tool<a href="#bib23" class="usa-link" aria-describedby="bib23"><sup>23</sup></a> for randomized controlled trials and the Newcastle-Ottawa Scale<a href="#bib24" class="usa-link" aria-describedby="bib24"><sup>24</sup></a> for observational studies. Using the Cochrane risk of bias tool, the following 7 domains were evaluated: random-sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of data, selective reporting, and other biases. Each domain was assessed based on low, unclear, or high risk of bias. Using the Newcastle-Ottawa Scale, a total of 8 domains, namely representativeness, selection, exposure ascertainment, the outcome at baseline, comparability, outcome assessment, follow-up duration, and adequacy of follow-up, were used for scoring the study quality.</p>
<p id="p0065">All statistical analyses were performed using R, version 4.2.1 (Rstudio). Dichotomous variables were reported as numbers (proportions), and continuous variables were shown as mean ± SD or median (IQR). Risk ratios (RRs) with 95% confidence intervals (CI) were calculated for a dichotomous outcome according to the random-effects model, and standard mean differences (SMDs) were presented for the comparisons of the changes of continuous variables before and after tafamidis treatment. The heterogeneity within the included studies was assessed based on Cochran's Q test and Higgins I<sup>2</sup> values. I<sup>2</sup> values of 25%, 50%, and 75% showed mild, moderate, and high heterogeneity, respectively. Subgroup analysis was performed for exploring heterogeneity. We performed sensitivity analysis and Begg’s test which was used to test publication bias. The analysis was considered significant when <em>P</em> &lt; 0.05.</p></section><section id="sec2.3"><h3 class="pmc_sec_title">Role of the funding source</h3>
<p id="p0070">The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to all the data used in the study and accept the final responsibility for the decision to submit to the publication.</p></section></section><section id="sec3"><h2 class="pmc_sec_title">Results</h2>
<section id="sec3.1"><h3 class="pmc_sec_title">Study selection and patients’ characteristics</h3>
<p id="p0075">The systematic literature search identified 3437 related studies, including 415 from PubMed, 1320 from Ovid Embase, 128 from Cochrane Library, 855 from Scopus and 719 from Web of Science. 1728 articles were further screened based on title and abstract after the removal of duplicates. The full texts of 37 articles were reviewed. Ten conference abstracts, 8 articles<a href="#bib25" class="usa-link" aria-describedby="bib25">25</a>, <a href="#bib26" class="usa-link" aria-describedby="bib26">26</a>, <a href="#bib27" class="usa-link" aria-describedby="bib27">27</a>, <a href="#bib28" class="usa-link" aria-describedby="bib28">28</a>, <a href="#bib29" class="usa-link" aria-describedby="bib29">29</a>, <a href="#bib30" class="usa-link" aria-describedby="bib30">30</a>, <a href="#bib31" class="usa-link" aria-describedby="bib31">31</a>, <a href="#bib32" class="usa-link" aria-describedby="bib32">32</a> with overlapping data from the ATTR-ACT study,<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> and 4 studies<a href="#bib33" class="usa-link" aria-describedby="bib33">33</a>, <a href="#bib34" class="usa-link" aria-describedby="bib34">34</a>, <a href="#bib35" class="usa-link" aria-describedby="bib35">35</a>, <a href="#bib36" class="usa-link" aria-describedby="bib36">36</a> without available data for analysis were excluded. Finally, fifteen articles,<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>, <a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>, <a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>, <a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib14" class="usa-link" aria-describedby="bib14">14</a>, <a href="#bib15" class="usa-link" aria-describedby="bib15">15</a>, <a href="#bib16" class="usa-link" aria-describedby="bib16">16</a><sup>,</sup><a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>, <a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>, <a href="#bib21" class="usa-link" aria-describedby="bib21">21</a>, <a href="#bib22" class="usa-link" aria-describedby="bib22">22</a> involving a total of 2765 patients, were included in the meta-analysis. The study and patient characteristics are summarized in <a href="#tbl1" class="usa-link">Table 1</a> and <a href="#tbl2" class="usa-link">Table 2</a>. 1251 (45.2%) of 2765 patients with ATTR-CM received tafamidis treatment. The weighted mean age of patients was 75.9 ± 9.3 years, and 2316 (83.7%) patients were male. The average follow-up duration was 18.7 ± 17.1 months. 678 (28.0%) patients died or received heart transplantation in nine studies.<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>, <a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>, <a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>, <a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib14" class="usa-link" aria-describedby="bib14">14</a> In addition, a total of 1060 patients with wild-type ATTR (wtATTR) in 4 articles<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>,</sup><a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a><sup>,</sup><a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a><sup>,</sup><a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> and 78 patients with hereditary ATTR (hATTR) in 1 article<a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a> were included for subgroup analysis. A flowchart of the study is shown in <a href="#fig1" class="usa-link">Fig. 1</a>. A detailed risk of bias analysis for the included studies is presented in <a href="#appsec1" class="usa-link">Supplementary Table S1</a> and <a href="#appsec1" class="usa-link">Supplementary Table S2</a>.</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline characteristics of the included studies.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">First author</th>
<th colspan="1" rowspan="1">Published year</th>
<th colspan="1" rowspan="1">Study type</th>
<th colspan="1" rowspan="1">Patients, no.</th>
<th colspan="1" rowspan="1">The median follow-up duration, months</th>
<th colspan="1" rowspan="1">Treatment</th>
<th colspan="1" rowspan="1">Patient population<a href="#tbl1fna" class="usa-link"><sup>a</sup></a>
</th>
<th colspan="1" rowspan="1">Endpoint</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Merlini et al.<a href="#bib21" class="usa-link" aria-describedby="bib21"><sup>21</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">Phase II</td>
<td align="center" colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">Tafamidis 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic; cardio-neuropathic; neuropathic</td>
<td colspan="1" rowspan="1">Only include for the analysis of changes in LVEF and IVS</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Maurer et al.<a href="#bib20" class="usa-link" aria-describedby="bib20"><sup>20</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2015</td>
<td colspan="1" rowspan="1">Phase II</td>
<td align="center" colspan="1" rowspan="1">35</td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">Tafamidis 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">Only include for the analysis of changes in LVEF and IVS</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sultan et al.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">64</td>
<td colspan="1" rowspan="1">13.6 ± 5.6<a href="#tbl1fnb" class="usa-link"><sup>b</sup></a>
</td>
<td colspan="1" rowspan="1">Tafamidis 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">All-cause death</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rosenblum et al.<a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">120</td>
<td colspan="1" rowspan="1">22.8 (12–33.6)</td>
<td colspan="1" rowspan="1">Tafamidis, diflunisal<a href="#tbl1fnc" class="usa-link"><sup>c</sup></a>
</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">All-cause death and OHT</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Maurer et al.<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">Phase III</td>
<td align="center" colspan="1" rowspan="1">441</td>
<td colspan="1" rowspan="1">30</td>
<td colspan="1" rowspan="1">Tafamidis 80 mg/d or 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">All-cause death, heart transplant, and cardiac mechanical assist devices</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gospodinova et al.<a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">Prospective</td>
<td align="center" colspan="1" rowspan="1">78</td>
<td colspan="1" rowspan="1">30 (15–48)</td>
<td colspan="1" rowspan="1">Tafamidis 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic; cardio-neuropathic</td>
<td colspan="1" rowspan="1">All-cause death</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bézard et al.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">Prospective</td>
<td align="center" colspan="1" rowspan="1">646</td>
<td colspan="1" rowspan="1">21.0 (6.2–45.2)</td>
<td colspan="1" rowspan="1">Tafamidis 80 mg/d or 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic; cardio-neuropathic; neuropathic</td>
<td colspan="1" rowspan="1">All-cause death, heart transplant, and cardiac decompensation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ochi et al.<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">82</td>
<td colspan="1" rowspan="1">16.7 (8.8–23.8)</td>
<td colspan="1" rowspan="1">Tafamidis 80 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">All-cause death, HF hospitalizations, and pacemaker implantation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hussain et al.<a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">Prospective</td>
<td align="center" colspan="1" rowspan="1">107</td>
<td colspan="1" rowspan="1">13.5</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">Death, hospitalization for heart failure</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Giblin et al.<a href="#bib22" class="usa-link" aria-describedby="bib22"><sup>22</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">45</td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">Tafamidis 61 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">Only include for the analysis of changes in LVEF, IVS, and GLS</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ichikawa et al.<a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">16 ± 8</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">Only include for the analysis of changes in LVEF, IVS, and GLS</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ghoneem et al.<a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">842<a href="#tbl1fnd" class="usa-link"><sup>d</sup></a>
</td>
<td colspan="1" rowspan="1">12</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">All-cause death, heart failure exacerbations</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Takashio et al.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">66<a href="#tbl1fnd" class="usa-link"><sup>d</sup></a>
</td>
<td colspan="1" rowspan="1">37.5 ± 18.1</td>
<td colspan="1" rowspan="1">Tafamidis 80 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">All-cause death, heart failure hospitalization</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rettl et al.<a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Prospective</td>
<td align="center" colspan="1" rowspan="1">137</td>
<td colspan="1" rowspan="1">9.5 ± 5.1<a href="#tbl1fnb" class="usa-link"><sup>b</sup></a>
</td>
<td colspan="1" rowspan="1">Tafamidis 61 mg/d or 20 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">Only include for the analysis of changes in LVEF, IVS, and GLS</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Chamling et al.<a href="#bib19" class="usa-link" aria-describedby="bib19"><sup>19</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Retrospective</td>
<td align="center" colspan="1" rowspan="1">40</td>
<td colspan="1" rowspan="1">12 ± 3<a href="#tbl1fnb" class="usa-link"><sup>b</sup></a>
</td>
<td colspan="1" rowspan="1">Tafamidis 61 mg/d</td>
<td colspan="1" rowspan="1">Cardiomyopathic</td>
<td colspan="1" rowspan="1">Only include for the analysis of changes in LVEF and GLS</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn2"><p>NI = not included; ATTR = transthyretin amyloidosis; OHT = orthotopic heart transplant; HF = heart failure; LVEF = left ventricular ejection fraction; IVS = intraventricular septum; GLS = global longitudinal strain.</p></div>
<div class="fn" id="tbl1fna">
<sup>a</sup><p class="display-inline" id="ntpara0015">The 15 patients with pure neuropathy were excluded from the meta-analysis.</p>
</div>
<div class="fn" id="tbl1fnb">
<sup>b</sup><p class="display-inline" id="ntpara0020">The average follow-up time of the included patients.</p>
</div>
<div class="fn" id="tbl1fnc">
<sup>c</sup><p class="display-inline" id="ntpara0025">13 patients receiving diflunisal in this study were excluded from the meta-analysis.</p>
</div>
<div class="fn" id="tbl1fnd">
<sup>d</sup><p class="display-inline" id="ntpara0030">The numbers of patients were from cohorts after propensity score matched.</p>
</div>
</div></section><section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Patients' demographic and clinical characteristics.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">First author</th>
<th colspan="1" rowspan="1">Published year</th>
<th colspan="1" rowspan="1">Patients, no.</th>
<th colspan="1" rowspan="1">Treatment group</th>
<th colspan="1" rowspan="1">Age, years</th>
<th colspan="1" rowspan="1">Male, no. (%)</th>
<th colspan="1" rowspan="1">NYHA class ≤ Ⅱ, no. (%)</th>
<th colspan="1" rowspan="1">hATTR, no. (%)</th>
<th colspan="1" rowspan="1">White, no. (%)</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Merlini et al.<a href="#bib21" class="usa-link" aria-describedby="bib21"><sup>21</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2013</td>
<td align="center" colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">63.1 ± 9.9</td>
<td align="center" colspan="1" rowspan="1">13 (62)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">21 (100)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Maurer et al.<a href="#bib20" class="usa-link" aria-describedby="bib20"><sup>20</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2015</td>
<td align="center" colspan="1" rowspan="1">35</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">76.7 (68.7–86.5)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">29 (83)</td>
<td colspan="1" rowspan="1">30 (86)</td>
<td colspan="1" rowspan="1">4 (11)</td>
<td colspan="1" rowspan="1">35 (100)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sultan et al.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2017</td>
<td align="center" colspan="1" rowspan="1">29</td>
<td colspan="1" rowspan="1">TRACS (without tafamidis)</td>
<td colspan="1" rowspan="1">73.8 ± 5.7</td>
<td align="center" colspan="1" rowspan="1">27 (93)</td>
<td colspan="1" rowspan="1">22 (75.6)</td>
<td colspan="1" rowspan="1">11 (38)</td>
<td colspan="1" rowspan="1">18 (62)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">35</td>
<td colspan="1" rowspan="1">Fx1B-201 (On tafamidis)</td>
<td colspan="1" rowspan="1">76.4 ± 4.6</td>
<td align="center" colspan="1" rowspan="1">32 (91)</td>
<td colspan="1" rowspan="1">33 (94)</td>
<td colspan="1" rowspan="1">4 (11)</td>
<td colspan="1" rowspan="1">32 (91)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rosenblum et al.<a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2018</td>
<td align="center" colspan="1" rowspan="1">29</td>
<td colspan="1" rowspan="1">On stabilizer<a href="#tbl2fna" class="usa-link"><sup>a</sup></a>
</td>
<td colspan="1" rowspan="1">75 ± 9</td>
<td align="center" colspan="1" rowspan="1">28 (97)</td>
<td colspan="1" rowspan="1">23 (79)</td>
<td colspan="1" rowspan="1">3 (10)</td>
<td colspan="1" rowspan="1">27 (93)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">91</td>
<td colspan="1" rowspan="1">Not on stabilizer</td>
<td colspan="1" rowspan="1">75 ± 8</td>
<td align="center" colspan="1" rowspan="1">77 (85)</td>
<td colspan="1" rowspan="1">36 (40)</td>
<td colspan="1" rowspan="1">33 (36)</td>
<td colspan="1" rowspan="1">50 (55)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Maurer et al.<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2018</td>
<td align="center" colspan="1" rowspan="1">264</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">74.5 ± 7.2</td>
<td align="center" colspan="1" rowspan="1">241 (91.3)</td>
<td colspan="1" rowspan="1">186 (70.5)</td>
<td colspan="1" rowspan="1">63 (23.9)</td>
<td colspan="1" rowspan="1">211 (79.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">177</td>
<td colspan="1" rowspan="1">Placebo</td>
<td colspan="1" rowspan="1">74.1 ± 6.7</td>
<td align="center" colspan="1" rowspan="1">157 (88.7)</td>
<td colspan="1" rowspan="1">114 (64.4)</td>
<td colspan="1" rowspan="1">43 (24.3)</td>
<td colspan="1" rowspan="1">146 (82.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gospodinova et al.<a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2020</td>
<td align="center" colspan="1" rowspan="1">60</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">56 (54–61)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">39 (50)</td>
<td colspan="1" rowspan="1">49 (63)</td>
<td colspan="1" rowspan="1">78 (100)</td>
<td colspan="1" rowspan="1">78 (100)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">18</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bézard et al.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2021</td>
<td align="center" colspan="1" rowspan="1">98</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">69 ± 10</td>
<td align="center" colspan="1" rowspan="1">73 (74)</td>
<td colspan="1" rowspan="1">52 (57)</td>
<td colspan="1" rowspan="1">81 (83)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">533</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">78 ± 9</td>
<td align="center" colspan="1" rowspan="1">443 (83.1)</td>
<td colspan="1" rowspan="1">271 (55.8)</td>
<td colspan="1" rowspan="1">127 (23.8)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ochi et al.<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2022</td>
<td align="center" colspan="1" rowspan="1">38</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">78.4 ± 5.9</td>
<td align="center" colspan="1" rowspan="1">33 (87)</td>
<td colspan="1" rowspan="1">33 (92)</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">44</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">84.3 ± 4.6</td>
<td align="center" colspan="1" rowspan="1">38 (86)</td>
<td colspan="1" rowspan="1">13 (30)</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hussain et al.<a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2022</td>
<td align="center" colspan="1" rowspan="1">63</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">83.6 (80.5–88.5)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">53 (84.1)</td>
<td colspan="1" rowspan="1">22 (41.5)</td>
<td colspan="1" rowspan="1">2 (3.2)</td>
<td colspan="1" rowspan="1">56 (88.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">44</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">84.2 (79.7–90.3)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">32 (72.7)</td>
<td colspan="1" rowspan="1">7 (20.6)</td>
<td colspan="1" rowspan="1">2 (4.5)</td>
<td colspan="1" rowspan="1">33 (75)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Giblin et al.<a href="#bib22" class="usa-link" aria-describedby="bib22"><sup>22</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2022</td>
<td align="center" colspan="1" rowspan="1">23</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">79.1 ± 6.0</td>
<td align="center" colspan="1" rowspan="1">23 (100)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">2 (9)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">22</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">78.2 ± 6.7</td>
<td align="center" colspan="1" rowspan="1">22 (91)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">1 (5)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ichikawa et al.<a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td align="center" colspan="1" rowspan="1">41</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">75.6 ± 6.9</td>
<td align="center" colspan="1" rowspan="1">37 (90.2)</td>
<td colspan="1" rowspan="1">33 (80.5)</td>
<td colspan="1" rowspan="1">7 (17.1)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ghoneem et al.<a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td align="center" colspan="1" rowspan="1">421<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">76.8 ± 8.6</td>
<td align="center" colspan="1" rowspan="1">361 (85.7)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">268 (63.7)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">421<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">76.2 ± 9.0</td>
<td align="center" colspan="1" rowspan="1">365 (86.7)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">270 (64.1)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Takashio et al.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td align="center" colspan="1" rowspan="1">33<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">77.3 ± 6.8</td>
<td align="center" colspan="1" rowspan="1">30 (91)</td>
<td colspan="1" rowspan="1">21 (64)</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">33<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">77.0 ± 5.6</td>
<td align="center" colspan="1" rowspan="1">27 (82)</td>
<td colspan="1" rowspan="1">18 (55)</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rettl et al.<a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2023</td>
<td align="center" colspan="1" rowspan="1">62</td>
<td colspan="1" rowspan="1">Tafamidis 61 mg</td>
<td colspan="1" rowspan="1">78.5 (6.6)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">50 (81)</td>
<td colspan="1" rowspan="1">29 (47)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">21</td>
<td colspan="1" rowspan="1">Tafamidis 20 mg</td>
<td colspan="1" rowspan="1">74.1 (5.9)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">19 (91)</td>
<td colspan="1" rowspan="1">13 (62)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">54</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">78.0 (8.0)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">44 (82)</td>
<td colspan="1" rowspan="1">29 (54)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Chamling et al.<a href="#bib19" class="usa-link" aria-describedby="bib19"><sup>19</sup></a>
</td>
<td colspan="1" rowspan="1">2023</td>
<td align="center" colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">Tafamidis</td>
<td colspan="1" rowspan="1">76 (73–81)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">18 (90)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">Without tafamidis</td>
<td colspan="1" rowspan="1">80 (75–82)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">15 (75)</td>
<td colspan="1" rowspan="1">NR</td>
<td colspan="1" rowspan="1">0 (0)</td>
<td colspan="1" rowspan="1">NR</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tspara0025"><p>The values are mean ± standard deviation, unless otherwise indicated.</p></div>
<div class="fn" id="tspara0030"><p>NR = not reported; NYHA = New York Heart Association; hATTR = hereditary transthyretin amyloidosis.</p></div>
<div class="fn" id="tbl2fna">
<sup>a</sup><p class="display-inline" id="ntpara0035">Stabilizer includes diflunisal and tafamidis; 13 patients receiving diflunisal in this study were excluded from the meta-analysis.</p>
</div>
<div class="fn" id="tbl2fnb">
<sup>b</sup><p class="display-inline" id="ntpara0040">The value was presented as median (IQR).</p>
</div>
<div class="fn" id="tbl2fnc">
<sup>c</sup><p class="display-inline" id="ntpara0045">All data of patients were from cohorts after propensity score matched.</p>
</div>
</div></section><figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10474377_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf48/10474377/73133c88b9bb/gr1.jpg" loading="lazy" height="793" width="750" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Flowchart for included studies for the</strong><strong>meta-analysis.</strong></p></figcaption></figure></section><section id="sec3.2"><h3 class="pmc_sec_title">Outcomes</h3>
<section id="sec3.2.1"><h4 class="pmc_sec_title">The primary endpoint: all-cause death or heart transplantation</h4>
<p id="p0080">Nine studies,<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>, <a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>, <a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>, <a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib14" class="usa-link" aria-describedby="bib14">14</a> involving a total of 2418 patients, were included to analyse the relationship between tafamidis and the primary endpoint of all-cause death or heart transplantation. 194 (18.9%) of 1028 patients that received tafamidis treatment reached the primary endpoint while 484 (34.8%) of 1390 patients without tafamidis treatment reached the primary endpoint. Patients who received tafamidis treatment were associated with a significantly lower RR (RR, 0.44; 95% CI, 0.31–0.65; <em>P</em> &lt; 0.01; <a href="#fig2" class="usa-link">Fig. 2</a>A) compared to the patients who did not receive tafamidis with a significant heterogeneity (I<sup>2</sup> = 79%, <em>P</em> &lt; 0.01). A subgroup analysis according to ATTR type showed that no significant difference of tafamidis on primary endpoint was identified between wtATTR and hATTR (RR, 0.44; 95% CI, 0.27–0.73 <em>versus</em> 0.21; 95% CI, 0.11–0.40, <em>P</em> = 0.08; I<sup>2</sup> = 68%) (<a href="#fig2" class="usa-link">Fig. 2</a>B). The results remained valid after the removal of the study from Bezard et al.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a> (<a href="#appsec1" class="usa-link">Supplementary Figure S1A</a>). There was significant publication bias (<em>P</em> = 0.04) while the sensitivity analysis revealed that the overall effect size remained robust when each study was removed in turn (<a href="#appsec1" class="usa-link">Supplementary Figure S2A</a>). In addition, subgroup analysis showed there was no significant publication bias by Begg’s test (<em>P</em> = 0.5).</p>
<figure class="fig xbox font-sm" id="fig2"><h5 class="obj_head">Fig. 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10474377_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf48/10474377/2923237e7c5f/gr2.jpg" loading="lazy" height="755" width="750" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Pooled RR of tafamidis treatment for death or heart transplantation.</strong> The pooled RR for the all-cause death or heart transplantation (A) in patients with ATTR-CM and the subgroup analysis by types of ATTR (B). ATTR-CM = transthyretin amyloid cardiomyopathy; No. = number; RR = risk ratio.</p></figcaption></figure></section><section id="sec3.2.2"><h4 class="pmc_sec_title">The composite endpoints</h4>
<p id="p0085">The same nine studies<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>, <a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>, <a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>, <a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib14" class="usa-link" aria-describedby="bib14">14</a> were used to analyse the impact of tafamidis on the composite endpoint of all-cause death, heart transplant, heart assist device implantation, heart failure exacerbations and hospitalizations. During the follow-up period, 354 (34.4%) of 1028 patients reached the composite endpoint in the group with tafamidis treatment, while 640 (46.0%) of 1390 patients reached the composite endpoint in patients without tafamidis treatment. Patients that received tafamidis treatment were associated with a significantly lower RR (RR, 0.57; 95% CI, 0.42–0.77; <em>P</em> &lt; 0.01; <a href="#fig3" class="usa-link">Fig. 3</a>A) compared to the patients that did not with a significant heterogeneity (I<sup>2</sup> = 82%, <em>P</em> &lt; 0.01). Subgroup analysis according to ATTR type showed that tafamidis treatment decreased the risk of composite endpoint in both wtATTR and hATTR, respectively (wtATTR: RR, 0.59; 95% CI, 0.36–0.97, <em>P</em> = 0.04; hATTR: 0.21; 95% CI, 0.11–0.40, <em>P</em> &lt; 0.01) (<a href="#fig3" class="usa-link">Fig. 3</a>B). The results remained valid after the removal of the study from Bezard et al.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a> (<a href="#appsec1" class="usa-link">Supplementary Figure S1B</a>). There was significant publication bias (<em>P</em> = 0.04) while the sensitivity analysis revealed that the overall effect size remained robust when each study was removed in turn (<a href="#appsec1" class="usa-link">Supplementary Figure S2B</a>). In addition, subgroup analysis showed there was no significant publication bias by Begg’s test (<em>P</em> = 0.17).</p>
<figure class="fig xbox font-sm" id="fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10474377_gr3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf48/10474377/25c1f2bc9b14/gr3.jpg" loading="lazy" height="834" width="750" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Pooled RR of tafamidis treatment for the composite endpoint.</strong> The pooled RR for the composite endpoint (A) in patients with ATTR-CM and the subgroup analysis by types of ATTR (B). ATTR-CM = transthyretin amyloid cardiomyopathy; No. = number; RR = risk ratio.</p></figcaption></figure></section><section id="sec3.2.3"><h4 class="pmc_sec_title">Cardiac remodeling in patients with and without tafamidis treatment</h4>
<p id="p0090">Nine studies,<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>,</sup><a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a><sup>,</sup><a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a><sup>,</sup><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a><sup>,</sup><a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a><sup>,</sup><a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>, <a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>, <a href="#bib21" class="usa-link" aria-describedby="bib21">21</a>, <a href="#bib22" class="usa-link" aria-describedby="bib22">22</a> involving a total of 398 patients, were analysed to compare the differences of LVEF, IVS, and GLS on echocardiograms or CMR after receiving tafamidis in patients with ATTR-CM. There was a significant decrease in LVEF (SMD, −0.17; 95% CI, −0.31 to −0.03; <em>P</em> = 0.02; <a href="#fig4" class="usa-link">Fig. 4</a>) after tafamidis treatment. However, subgroup analysis by types of ATTR showed no significant deterioration in LVEF in the patients with wtATTR after tafamidis treatment (SMD, −0.11; 95% CI, −0.34 to 0.12, <em>P</em> = 0.34). In addition, there was no significant change in IVS (entire group: SMD, 0.06, 95% CI, −0.09 to 0.21, <em>P</em> = 0.42; <a href="#fig4" class="usa-link">Fig. 4</a>; wtATTR: SMD, −0.09; 95% CI, −0.34 to 0.16, <em>P</em> = 0.49; hATTR: SMD, 0.27; 95% CI, −0.08 to 0.63, <em>P</em> = 0.13, <a href="#fig5" class="usa-link">Fig. 5</a>) and GLS (SMD, 0.12, 95% CI, −0.03 to 0.27, <em>P</em> = 0.11; <a href="#fig4" class="usa-link">Fig. 4</a>, wtATTR: SMD, 0.23, 95% CI, −0.14 to 0.59, <em>P</em> = 0.23; hATTR: SMD, 0.05, 95% CI, −0.31 to 0.40, <em>P</em> = 0.8, <a href="#fig5" class="usa-link">Fig. 5</a>) in the entire ATTR-CM or the subgroups with wtATTR or hATTR after tafamidis treatment. No significant heterogeneity was identified across changes of LVEF (I<sup>2</sup> = 0%, <em>P</em> = 0.57) and IVS (I<sup>2</sup> = 0%, <em>P</em> = 0.78), and GLS (I<sup>2</sup> = 0%, <em>P</em> = 0.58). Begg’s test suggested that there was no significant publication bias within included studies (<em>P</em> = 0.83 for LVEF changes; <em>P</em> = 0.62 for IVS changes; <em>P</em> = 0.051 for GLS changes).</p>
<figure class="fig xbox font-sm" id="fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10474377_gr4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf48/10474377/1f2b7050d626/gr4.jpg" loading="lazy" height="876" width="751" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Pooled SMD of tafamidis treatment for changes in LVEF, IVS, and GLS in patients with ATTR-CM.</strong> The pooled SMD represented the changes from baseline to follow-up after tafamidis treatment. ATTR-CM = transthyretin amyloid cardiomyopathy; SMD = standard mean difference; LVEF = left ventricular ejection fraction; IVS = intraventricular septum; GLS = global longitudinal strain.</p></figcaption></figure><figure class="fig xbox font-sm" id="fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=10474377_gr5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf48/10474377/835ce1bde6eb/gr5.jpg" loading="lazy" height="1330" width="690" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>Subgroup analysis of tafamidis treatment for changes in LVEF, IVS, and GLS in patients with wtATTR and hATTR.</strong> ATTR-CM = transthyretin amyloid cardiomyopathy; wtATTR = wild-type ATTR; hATTR = hereditary ATTR; SMD = standard mean difference; LVEF = left ventricular ejection fraction; IVS = intraventricular septum; GLS = global longitudinal strain.</p></figcaption></figure></section></section></section><section id="sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p id="p0095">This meta-analysis summarized fifteen different published studies and evaluated the impact of tafamidis on prognosis in patients with ATTR. Our findings suggested that tafamidis treatment was statistically significantly associated with reductions in all-cause death or heart transplantation and composite endpoints in patients with the entire ATTR or the subgroups with wtATTR or hATTR. In addition, our study revealed no significant deterioration in LVEF in the patients with wtATTR after tafamidis treatment, which indicated that the responsiveness to tafamidis treatment may be better in the patients with wtATTR than hATTR.</p>
<p id="p0100">Previous studies demonstrated that LVEF decreased with disease progression in ATTR. In our meta-analysis, we also found that there was a significant decrease in LVEF despite tafamidis treatment, which is consistent with the study by Maurer et al.<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> Maurer et al. demonstrated that, although LVEF decreased in patients with tafamidis treatment, there was a smaller decrease in LVEF in 264 patients who received tafamidis compared to 177 patients who received placebo from baseline at 30 months (tafamidis group: denotes least square (LS) mean LVEF: −2.82% (standard error (SE) = 0.85); placebo group: LS mean LVEF: −4.34% (SE = 1.10).<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> This relatively lower reduction in LVEF in patients receiving tafamidis suggests that tafamidis halts disease progression in ATTR.</p>
<p id="p0105">A previous meta-analysis<a href="#bib37" class="usa-link" aria-describedby="bib37"><sup>37</sup></a> reported that the patients with wtATTR were associated with higher survival compared with hATTR. In addition, within the cohort of patients with hATTR, the patients with the Val30Met variant had a more benign course and better survival than the patients with Val122Ile or Thr60Ala variant, which highlighted the possibility that the natural course or responsiveness to tafamidis treatment may be different between the genetic variants. Our study reported no significant deterioration in LVEF in the patients with wtATTR rather than hATTR after tafamidis treatment by the subgroup analysis, reflecting that the responsiveness to tafamidis treatment may be better in the patients with wtATTR than hATTR. These results need to be further validated within a larger sample and the impact of tafamidis on functional changes by echocardiography or CMR in hATTR with different variants needs to be further explored.</p>
<p id="p0110">Additionally, previous studies reported that patients that received tafamidis had an improvement in physical performance, 6-min walk distance, N-terminal prohormone of brain natriuretic peptide, and the Kansas City Cardiomyopathy Questionnaire–Overall Summary score.<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a><sup>,</sup><a href="#bib20" class="usa-link" aria-describedby="bib20"><sup>20</sup></a><sup>,</sup><a href="#bib38" class="usa-link" aria-describedby="bib38"><sup>38</sup></a> These results supported that tafamidis treatment helps improve quality of life by halting disease progression.</p>
<p id="p0115">Several previous studies reported patients with ATTR-CM that received tafamidis treatment were associated with a lower risk of a heart transplant, all-cause death, or cardiovascular-related hospitalizations. The primary composite endpoint was evaluated in 1 RCT trial and 8 non-RCT studies. The RCT study of the placebo-controlled phase 3 study showed that all-cause mortality and cardiovascular-related hospitalizations were both lower in patients with the treatment of tafamidis compared with the placebo over the 30-month follow-up (all-cause mortality: HR, 0.70; 95% CI, 0.51–0.96; cardiovascular-related hospitalizations: relative risk ratio, 0.68; 95% CI, 0.56–0.81).<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> Another retrospective study, including 122 patients with ATTR-CM, also showed a similar reduction in death or heart transplant under the treatment of stabilizers based on multivariable Cox analysis (hazard ratio, 0.37; 95% confidence interval, 0.19–0.75; <em>P</em> = 0.003).<a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a> In addition, 3 real-world studies reported that patients treated with tafamidis had reduced risk of all-cause mortality or cardiovascular-related hospitalization compared with untreated patients.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>,</sup><a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a><sup>,</sup><a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> Our systematic meta-analysis is in agreement with prior studies, highlighting the survival benefit of tafamidis treatment, which strengthens the evidence for recommendations for the treatment of patients with ATTR-CM. In addition, our subgroup analysis of ATTR types affirms that tafamidis treatment could reduce risk in both wtATTR and hATTR.</p>
<p id="p0120">Our meta-analysis has several limitations. First, only 1 RCT was included in the analysis. Second, the included studies had a mean follow-up duration of approximately 20 months, thereby necessitating further research to determine the longer-term efficacy of tafamidis. Third, the sample size of hATTR was relatively small. Fourth, the heterogeneity remained moderate even after subgroup analyses by types of ATTR. Nonetheless, this meta-analysis of available data provides evidence supporting favorable outcomes of tafamidis in patients with ATTR-CM.</p>
<p id="p0125">According to our findings, in patients with ATTR-CM, tafamidis treatment was associated with a low risk of all-cause death, heart transplant, heart assist device implantation, heart failure exacerbations or hospitalizations. In addition, tafamidis treatment may decrease deterioration in LVEF in patients with wtATTR. Further research, encompassing larger sample sizes and long-term follow-up, is warranted to evaluate the efficacy of tafamidis in the treatment of ATTR.</p></section><section id="sec5"><h2 class="pmc_sec_title">Contributors</h2>
<p id="p0130">JW, HYC, and ZHT participated in the design of the study, literature search, data extraction, data analysis, and interpretation, performed the statistical analysis, and wrote the original draft. Thus, these three authors contributed equally to this paper. YCC and GVG conceived, designed, and coordinated the study. YCC, YH, GVG, and HK edited and reviewed the manuscript. JQZ, YWX, KW, and HK carried out data acquisition. JQZ, YWX, and KW conducted the data analysis. JW, HYC, and ZHT registered the study in PROSPERO. JW and YCC verified the underlying data. All the authors had full access to all the data in the study and accept responsibility for the decision to submit for publication.</p></section><section id="sec6"><h2 class="pmc_sec_title">Data sharing statement</h2>
<p id="p0135">Once the data datasets have been de-identified and all the main findings have been published, all data will be shared upon request by the corresponding author (YCC) for research purposes.</p></section><section id="sec23"><h2 class="pmc_sec_title">Declaration of interests</h2>
<p id="p0140">All authors declare no competing interests.</p></section><section id="ack0010" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p id="p0145">The authors thank Dr. Mariana Gospodinova from the Clinic of Cardiology, Medical Institute, Ministry of Interior Sofia for helping us to confirm the information used in this study. This work was supported by grants from the Natural Science Foundation of Sichuan Province [Grant Number: 23NSFSC4589] and the National Natural Science Foundation of China [Grant Number: 82202248].</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="appsec2">
<sup>Appendix A</sup><p class="display-inline" id="p0155">Supplementary data related to this article can be found at <a href="https://doi.org/10.1016/j.eclinm.2023.102172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.eclinm.2023.102172</a>.</p>
</div></div></section><section id="appsec1"><h2 class="pmc_sec_title">Appendix A. Supplementary data</h2>
<section class="sm xbox font-sm" id="mmc1"><div class="caption p"><span>Supplemental Material</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/10474377/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (324.4KB, pdf) </sup>
</div></div></section></section><section id="cebib0010" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="cebib0010_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>Lane T., Fontana M., Martinez-Naharro A., et al.  Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 2019;140(1):16–26. doi: 10.1161/CIRCULATIONAHA.118.038169.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.118.038169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31109193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Natural%20history,%20quality%20of%20life,%20and%20outcome%20in%20cardiac%20transthyretin%20amyloidosis&amp;author=T.%20Lane&amp;author=M.%20Fontana&amp;author=A.%20Martinez-Naharro&amp;volume=140&amp;issue=1&amp;publication_year=2019&amp;pages=16-26&amp;pmid=31109193&amp;doi=10.1161/CIRCULATIONAHA.118.038169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>Castaño A., Narotsky D.L., Hamid N., et al.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J. 2017;38(38):2879–2887. doi: 10.1093/eurheartj/ehx350.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehx350" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5837725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29019612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Unveiling%20transthyretin%20cardiac%20amyloidosis%20and%20its%20predictors%20among%20elderly%20patients%20with%20severe%20aortic%20stenosis%20undergoing%20transcatheter%20aortic%20valve%20replacement&amp;author=A.%20Casta%C3%B1o&amp;author=D.L.%20Narotsky&amp;author=N.%20Hamid&amp;volume=38&amp;issue=38&amp;publication_year=2017&amp;pages=2879-2887&amp;pmid=29019612&amp;doi=10.1093/eurheartj/ehx350&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>González-López E., Gallego-Delgado M., Guzzo-Merello G., et al.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36(38):2585–2594. doi: 10.1093/eurheartj/ehv338.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26224076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Wild-type%20transthyretin%20amyloidosis%20as%20a%20cause%20of%20heart%20failure%20with%20preserved%20ejection%20fraction&amp;author=E.%20Gonz%C3%A1lez-L%C3%B3pez&amp;author=M.%20Gallego-Delgado&amp;author=G.%20Guzzo-Merello&amp;volume=36&amp;issue=38&amp;publication_year=2015&amp;pages=2585-2594&amp;pmid=26224076&amp;doi=10.1093/eurheartj/ehv338&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>Marques N., Azevedo O., Almeida A.R., et al.  Specific therapy for transthyretin cardiac amyloidosis: a systematic literature review and evidence-based recommendations. J Am Heart Assoc. 2020;9(19) doi: 10.1161/JAHA.120.016614.</cite> [<a href="https://doi.org/10.1161/JAHA.120.016614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7792401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32969287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Am%20Heart%20Assoc&amp;title=Specific%20therapy%20for%20transthyretin%20cardiac%20amyloidosis:%20a%20systematic%20literature%20review%20and%20evidence-based%20recommendations&amp;author=N.%20Marques&amp;author=O.%20Azevedo&amp;author=A.R.%20Almeida&amp;volume=9&amp;issue=19&amp;publication_year=2020&amp;pmid=32969287&amp;doi=10.1161/JAHA.120.016614&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>Bulawa C.E., Connelly S., Devit M., et al.  Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A. 2012;109(24):9629–9634. doi: 10.1073/pnas.1121005109.</cite> [<a href="https://doi.org/10.1073/pnas.1121005109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3386102/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22645360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Tafamidis,%20a%20potent%20and%20selective%20transthyretin%20kinetic%20stabilizer%20that%20inhibits%20the%20amyloid%20cascade&amp;author=C.E.%20Bulawa&amp;author=S.%20Connelly&amp;author=M.%20Devit&amp;volume=109&amp;issue=24&amp;publication_year=2012&amp;pages=9629-9634&amp;pmid=22645360&amp;doi=10.1073/pnas.1121005109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>Maurer M.S., Schwartz J.H., Gundapaneni B., et al.  Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–1016. doi: 10.1056/NEJMoa1805689.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&amp;title=Tafamidis%20treatment%20for%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy&amp;author=M.S.%20Maurer&amp;author=J.H.%20Schwartz&amp;author=B.%20Gundapaneni&amp;volume=379&amp;issue=11&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>Takashio S., Morioka M., Ishii M., et al.  Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy. ESC Heart Fail. 2023;10(4):2319–2329. doi: 10.1002/ehf2.14380.</cite> [<a href="https://doi.org/10.1002/ehf2.14380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10375127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37073415/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESC%20Heart%20Fail&amp;title=Clinical%20characteristics,%20outcome,%20and%20therapeutic%20effect%20of%20tafamidis%20in%20wild-type%20transthyretin%20amyloid%20cardiomyopathy&amp;author=S.%20Takashio&amp;author=M.%20Morioka&amp;author=M.%20Ishii&amp;volume=10&amp;issue=4&amp;publication_year=2023&amp;pages=2319-2329&amp;pmid=37073415&amp;doi=10.1002/ehf2.14380&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>Sultan M.B., Gundapaneni B., Schumacher J., Schwartz J.H. Treatment with tafamidis slows disease progression in early-stage transthyretin cardiomyopathy. Clin Med Insights Cardiol. 2017;11 doi: 10.1177/1179546817730322.</cite> [<a href="https://doi.org/10.1177/1179546817730322" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5606341/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28951660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Med%20Insights%20Cardiol&amp;title=Treatment%20with%20tafamidis%20slows%20disease%20progression%20in%20early-stage%20transthyretin%20cardiomyopathy&amp;author=M.B.%20Sultan&amp;author=B.%20Gundapaneni&amp;author=J.%20Schumacher&amp;author=J.H.%20Schwartz&amp;volume=11&amp;publication_year=2017&amp;pmid=28951660&amp;doi=10.1177/1179546817730322&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>Rosenblum H., Castano A., Alvarez J., Goldsmith J., Helmke S., Maurer M.S. TTR (Transthyretin) stabilizers are associated with improved survival in patients with TTR cardiac amyloidosis. Circ Heart Fail. 2018;11(4) doi: 10.1161/CIRCHEARTFAILURE.117.004769.</cite> [<a href="https://doi.org/10.1161/CIRCHEARTFAILURE.117.004769" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5886729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29615436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ%20Heart%20Fail&amp;title=TTR%20(Transthyretin)%20stabilizers%20are%20associated%20with%20improved%20survival%20in%20patients%20with%20TTR%20cardiac%20amyloidosis&amp;author=H.%20Rosenblum&amp;author=A.%20Castano&amp;author=J.%20Alvarez&amp;author=J.%20Goldsmith&amp;author=S.%20Helmke&amp;volume=11&amp;issue=4&amp;publication_year=2018&amp;pmid=29615436&amp;doi=10.1161/CIRCHEARTFAILURE.117.004769&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>Ochi Y., Kubo T., Baba Y., et al.  Early experience of tafamidis treatment in Japanese patients with wild-type transthyretin cardiac amyloidosis from the Kochi amyloidosis cohort. Circ J. 2022;86(7):1121–1128. doi: 10.1253/circj.CJ-21-0965.</cite> [<a href="https://doi.org/10.1253/circj.CJ-21-0965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35599003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ%20J&amp;title=Early%20experience%20of%20tafamidis%20treatment%20in%20Japanese%20patients%20with%20wild-type%20transthyretin%20cardiac%20amyloidosis%20from%20the%20Kochi%20amyloidosis%20cohort&amp;author=Y.%20Ochi&amp;author=T.%20Kubo&amp;author=Y.%20Baba&amp;volume=86&amp;issue=7&amp;publication_year=2022&amp;pages=1121-1128&amp;pmid=35599003&amp;doi=10.1253/circj.CJ-21-0965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>Hussain K., Macrinici V., Wathen L., et al.  Impact of tafamidis on survival in a real-world community-based cohort. Curr Probl Cardiol. 2022;47(12) doi: 10.1016/j.cpcardiol.2022.101358.</cite> [<a href="https://doi.org/10.1016/j.cpcardiol.2022.101358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35995245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Probl%20Cardiol&amp;title=Impact%20of%20tafamidis%20on%20survival%20in%20a%20real-world%20community-based%20cohort&amp;author=K.%20Hussain&amp;author=V.%20Macrinici&amp;author=L.%20Wathen&amp;volume=47&amp;issue=12&amp;publication_year=2022&amp;pmid=35995245&amp;doi=10.1016/j.cpcardiol.2022.101358&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>Gospodinova M., Sarafov S., Chamova T., et al.  Cardiac involvement, morbidity and mortality in hereditary transthyretin amyloidosis because of p.Glu89Gln mutation. J Cardiovasc Med. 2020;21(9):688–695. doi: 10.2459/JCM.0000000000001036.</cite> [<a href="https://doi.org/10.2459/JCM.0000000000001036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32740500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Cardiovasc%20Med&amp;title=Cardiac%20involvement,%20morbidity%20and%20mortality%20in%20hereditary%20transthyretin%20amyloidosis%20because%20of%20p.Glu89Gln%20mutation&amp;author=M.%20Gospodinova&amp;author=S.%20Sarafov&amp;author=T.%20Chamova&amp;volume=21&amp;issue=9&amp;publication_year=2020&amp;pages=688-695&amp;pmid=32740500&amp;doi=10.2459/JCM.0000000000001036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>Ghoneem A., Bhatti A.W., Khadke S., et al.  Real-world efficacy of tafamidis in patients with transthyretin amyloidosis and heart failure. Curr Probl Cardiol. 2023;48(6) doi: 10.1016/j.cpcardiol.2023.101667.</cite> [<a href="https://doi.org/10.1016/j.cpcardiol.2023.101667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36828040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Probl%20Cardiol&amp;title=Real-world%20efficacy%20of%20tafamidis%20in%20patients%20with%20transthyretin%20amyloidosis%20and%20heart%20failure&amp;author=A.%20Ghoneem&amp;author=A.W.%20Bhatti&amp;author=S.%20Khadke&amp;volume=48&amp;issue=6&amp;publication_year=2023&amp;pmid=36828040&amp;doi=10.1016/j.cpcardiol.2023.101667&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>Bezard M., Kharoubi M., Galat A., et al.  Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis. Arch Cardiovasc Dis Suppl. 2021;13(1):27–28. doi: 10.1002/ejhf.2028.</cite> [<a href="https://doi.org/10.1002/ejhf.2028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33094885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch%20Cardiovasc%20Dis%20Suppl&amp;title=Natural%20history%20and%20impact%20of%20treatment%20with%20tafamidis%20on%20major%20cardiovascular%20outcome-free%20survival%20time%20in%20a%20cohort%20of%20patients%20with%20transthyretin%20amyloidosis&amp;author=M.%20Bezard&amp;author=M.%20Kharoubi&amp;author=A.%20Galat&amp;volume=13&amp;issue=1&amp;publication_year=2021&amp;pages=27-28&amp;pmid=33094885&amp;doi=10.1002/ejhf.2028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>Rettl R., Duca F., Binder C., et al.  Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy. Amyloid. 2023;30(1):127–137. doi: 10.1080/13506129.2022.2131385.</cite> [<a href="https://doi.org/10.1080/13506129.2022.2131385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36251806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Impact%20of%20tafamidis%20on%20myocardial%20strain%20in%20transthyretin%20amyloid%20cardiomyopathy&amp;author=R.%20Rettl&amp;author=F.%20Duca&amp;author=C.%20Binder&amp;volume=30&amp;issue=1&amp;publication_year=2023&amp;pages=127-137&amp;pmid=36251806&amp;doi=10.1080/13506129.2022.2131385&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>Ichikawa Y., Oota E., Odajima S., et al.  Impact of tafamidis on echocardiographic cardiac function of patients with transthyretin cardiac amyloidosis. Circ J. 2023;87(4):508–516. doi: 10.1253/circj.CJ-22-0683.</cite> [<a href="https://doi.org/10.1253/circj.CJ-22-0683" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36878601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ%20J&amp;title=Impact%20of%20tafamidis%20on%20echocardiographic%20cardiac%20function%20of%20patients%20with%20transthyretin%20cardiac%20amyloidosis&amp;author=Y.%20Ichikawa&amp;author=E.%20Oota&amp;author=S.%20Odajima&amp;volume=87&amp;issue=4&amp;publication_year=2023&amp;pages=508-516&amp;pmid=36878601&amp;doi=10.1253/circj.CJ-22-0683&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>Page M.J., McKenzie J.E., Bossuyt P.M., et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=The%20PRISMA%202020%20statement:%20an%20updated%20guideline%20for%20reporting%20systematic%20reviews&amp;author=M.J.%20Page&amp;author=J.E.%20McKenzie&amp;author=P.M.%20Bossuyt&amp;volume=372&amp;publication_year=2021&amp;pages=n71&amp;pmid=33782057&amp;doi=10.1136/bmj.n71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>Liu N., Zhou Y., Lee J.J. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2021;21(1):111. doi: 10.1186/s12874-021-01308-8.</cite> [<a href="https://doi.org/10.1186/s12874-021-01308-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8168323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34074267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med%20Res%20Methodol&amp;title=IPDfromKM:%20reconstruct%20individual%20patient%20data%20from%20published%20Kaplan-Meier%20survival%20curves&amp;author=N.%20Liu&amp;author=Y.%20Zhou&amp;author=J.J.%20Lee&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pages=111&amp;pmid=34074267&amp;doi=10.1186/s12874-021-01308-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<span class="label">19.</span><cite>Chamling B., Bietenbeck M., Korthals D., et al.  Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging. Clin Res Cardiol. 2023;112(3):353–362. doi: 10.1007/s00392-022-02035-w.</cite> [<a href="https://doi.org/10.1007/s00392-022-02035-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9998574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35666277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Res%20Cardiol&amp;title=Therapeutic%20value%20of%20tafamidis%20in%20patients%20with%20wild-type%20transthyretin%20amyloidosis%20(ATTRwt)%20with%20cardiomyopathy%20based%20on%20cardiovascular%20magnetic%20resonance%20(CMR)%20imaging&amp;author=B.%20Chamling&amp;author=M.%20Bietenbeck&amp;author=D.%20Korthals&amp;volume=112&amp;issue=3&amp;publication_year=2023&amp;pages=353-362&amp;pmid=35666277&amp;doi=10.1007/s00392-022-02035-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>Maurer M.S., Grogan D.R., Judge D.P., et al.  Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail. 2015;8(3):519–526. doi: 10.1161/CIRCHEARTFAILURE.113.000890.</cite> [<a href="https://doi.org/10.1161/CIRCHEARTFAILURE.113.000890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25872787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circ%20Heart%20Fail&amp;title=Tafamidis%20in%20transthyretin%20amyloid%20cardiomyopathy:%20effects%20on%20transthyretin%20stabilization%20and%20clinical%20outcomes&amp;author=M.S.%20Maurer&amp;author=D.R.%20Grogan&amp;author=D.P.%20Judge&amp;volume=8&amp;issue=3&amp;publication_year=2015&amp;pages=519-526&amp;pmid=25872787&amp;doi=10.1161/CIRCHEARTFAILURE.113.000890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>Merlini G., Planté-Bordeneuve V., Judge D.P., et al.  Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis. J Cardiovasc Transl Res. 2013;6(6):1011–1020. doi: 10.1007/s12265-013-9512-x.</cite> [<a href="https://doi.org/10.1007/s12265-013-9512-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3838581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24101373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Cardiovasc%20Transl%20Res&amp;title=Effects%20of%20tafamidis%20on%20transthyretin%20stabilization%20and%20clinical%20outcomes%20in%20patients%20with%20non-Val30Met%20transthyretin%20amyloidosis&amp;author=G.%20Merlini&amp;author=V.%20Plant%C3%A9-Bordeneuve&amp;author=D.P.%20Judge&amp;volume=6&amp;issue=6&amp;publication_year=2013&amp;pages=1011-1020&amp;pmid=24101373&amp;doi=10.1007/s12265-013-9512-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<span class="label">22.</span><cite>Giblin G.T., Cuddy S.A.M., González-López E., et al.  Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2022;23(8):1029–1039. doi: 10.1093/ehjci/jeac049.</cite> [<a href="https://doi.org/10.1093/ehjci/jeac049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9303005/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35274130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J%20Cardiovasc%20Imaging&amp;title=Effect%20of%20tafamidis%20on%20global%20longitudinal%20strain%20and%20myocardial%20work%20in%20transthyretin%20cardiac%20amyloidosis&amp;author=G.T.%20Giblin&amp;author=S.A.M.%20Cuddy&amp;author=E.%20Gonz%C3%A1lez-L%C3%B3pez&amp;volume=23&amp;issue=8&amp;publication_year=2022&amp;pages=1029-1039&amp;pmid=35274130&amp;doi=10.1093/ehjci/jeac049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<span class="label">23.</span><cite>Sterne J.A.C., Savović J., Page M.J., et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366 doi: 10.1136/bmj.l4898.</cite> [<a href="https://doi.org/10.1136/bmj.l4898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31462531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=RoB%202:%20a%20revised%20tool%20for%20assessing%20risk%20of%20bias%20in%20randomised%20trials&amp;author=J.A.C.%20Sterne&amp;author=J.%20Savovi%C4%87&amp;author=M.J.%20Page&amp;volume=366&amp;publication_year=2019&amp;pmid=31462531&amp;doi=10.1136/bmj.l4898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<span class="label">24.</span><cite>Wells G.A., Shea B., O'Connell D., et al.   2015. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.</cite> [<a href="https://scholar.google.com/scholar_lookup?Wells%20G.A.,%20Shea%20B.,%20O'Connell%20D.,%20et%20al.%202015.%20The%20Newcastle-Ottawa%20Scale%20(NOS)%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib25">
<span class="label">25.</span><cite>Li B., Alvir J., Stewart M. Extrapolation of survival benefits in patients with transthyretin amyloid cardiomyopathy receiving tafamidis: analysis of the tafamidis in transthyretin cardiomyopathy clinical trial. Cardiol Ther. 2020;9(2):535–540. doi: 10.1007/s40119-020-00179-2.</cite> [<a href="https://doi.org/10.1007/s40119-020-00179-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7584686/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32524297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiol%20Ther&amp;title=Extrapolation%20of%20survival%20benefits%20in%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy%20receiving%20tafamidis:%20analysis%20of%20the%20tafamidis%20in%20transthyretin%20cardiomyopathy%20clinical%20trial&amp;author=B.%20Li&amp;author=J.%20Alvir&amp;author=M.%20Stewart&amp;volume=9&amp;issue=2&amp;publication_year=2020&amp;pages=535-540&amp;pmid=32524297&amp;doi=10.1007/s40119-020-00179-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib26">
<span class="label">26.</span><cite>Li H., Rozenbaum M., Casey M., Sultan M.B. Estimating the effect of tafamidis on cardiovascular-related hospitalization in NYHA class III patients with transthyretin amyloid cardiomyopathy in the presence of death. Cardiology. 2022;147(4):398–405. doi: 10.1159/000525883.</cite> [<a href="https://doi.org/10.1159/000525883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35853436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cardiology&amp;title=Estimating%20the%20effect%20of%20tafamidis%20on%20cardiovascular-related%20hospitalization%20in%20NYHA%20class%20III%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy%20in%20the%20presence%20of%20death&amp;author=H.%20Li&amp;author=M.%20Rozenbaum&amp;author=M.%20Casey&amp;author=M.B.%20Sultan&amp;volume=147&amp;issue=4&amp;publication_year=2022&amp;pages=398-405&amp;pmid=35853436&amp;doi=10.1159/000525883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib27">
<span class="label">27.</span><cite>Miller A.B., Januzzi J.L., O'Neill B.J., et al.  Causes of cardiovascular hospitalization and death in patients with transthyretin amyloid cardiomyopathy (from the tafamidis in transthyretin cardiomyopathy clinical trial [ATTR-ACT]) Am J Cardiol. 2021;148:146–150. doi: 10.1016/j.amjcard.2021.02.035.</cite> [<a href="https://doi.org/10.1016/j.amjcard.2021.02.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33667442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cardiol&amp;title=Causes%20of%20cardiovascular%20hospitalization%20and%20death%20in%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy%20(from%20the%20tafamidis%20in%20transthyretin%20cardiomyopathy%20clinical%20trial%20%5BATTR-ACT%5D)&amp;author=A.B.%20Miller&amp;author=J.L.%20Januzzi&amp;author=B.J.%20O'Neill&amp;volume=148&amp;publication_year=2021&amp;pages=146-150&amp;pmid=33667442&amp;doi=10.1016/j.amjcard.2021.02.035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib28">
<span class="label">28.</span><cite>Nativi-Nicolau J., Judge D.P., Hoffman J.E., et al.  Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT. ESC Heart Fail. 2021;8(5):3875–3884. doi: 10.1002/ehf2.13541.</cite> [<a href="https://doi.org/10.1002/ehf2.13541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8497209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34432383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ESC%20Heart%20Fail&amp;title=Natural%20history%20and%20progression%20of%20transthyretin%20amyloid%20cardiomyopathy:%20insights%20from%20ATTR-ACT&amp;author=J.%20Nativi-Nicolau&amp;author=D.P.%20Judge&amp;author=J.E.%20Hoffman&amp;volume=8&amp;issue=5&amp;publication_year=2021&amp;pages=3875-3884&amp;pmid=34432383&amp;doi=10.1002/ehf2.13541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib29">
<span class="label">29.</span><cite>Sperry B.W., Hanna M., Maurer M.S., et al.  Association of tafamidis with health status in patients with ATTR cardiac amyloidosis: a post hoc analysis of the ATTR-ACT randomized clinical trial. JAMA Cardiol. 2023;8(3):275–280. doi: 10.1001/jamacardio.2022.5251.</cite> [<a href="https://doi.org/10.1001/jamacardio.2022.5251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9996391/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36723935/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Cardiol&amp;title=Association%20of%20tafamidis%20with%20health%20status%20in%20patients%20with%20ATTR%20cardiac%20amyloidosis:%20a%20post%20hoc%20analysis%20of%20the%20ATTR-ACT%20randomized%20clinical%20trial&amp;author=B.W.%20Sperry&amp;author=M.%20Hanna&amp;author=M.S.%20Maurer&amp;volume=8&amp;issue=3&amp;publication_year=2023&amp;pages=275-280&amp;pmid=36723935&amp;doi=10.1001/jamacardio.2022.5251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib30">
<span class="label">30.</span><cite>Damy T., Garcia-Pavia P., Hanna M., et al.  Efficacy and safety of tafamidis doses in the tafamidis in transthyretin cardiomyopathy clinical trial (ATTR-ACT) and long-term extension study. Eur J Heart Fail. 2021;23(2):277–285. doi: 10.1002/ejhf.2027.</cite> [<a href="https://doi.org/10.1002/ejhf.2027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8048553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33070419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail&amp;title=Efficacy%20and%20safety%20of%20tafamidis%20doses%20in%20the%20tafamidis%20in%20transthyretin%20cardiomyopathy%20clinical%20trial%20(ATTR-ACT)%20and%20long-term%20extension%20study&amp;author=T.%20Damy&amp;author=P.%20Garcia-Pavia&amp;author=M.%20Hanna&amp;volume=23&amp;issue=2&amp;publication_year=2021&amp;pages=277-285&amp;pmid=33070419&amp;doi=10.1002/ejhf.2027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib31">
<span class="label">31.</span><cite>Rozenbaum M.H., Garcia A., Grima D., et al.  Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the tafamidis in transthyretin cardiomyopathy clinical trial (ATTR-ACT) and the open-label long-term extension studies. Eur Heart J Qual Care Clin Outcomes. 2022;8(5):529–538. doi: 10.1093/ehjqcco/qcab031.</cite> [<a href="https://doi.org/10.1093/ehjqcco/qcab031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9382662/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33895806/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J%20Qual%20Care%20Clin%20Outcomes&amp;title=Health%20impact%20of%20tafamidis%20in%20transthyretin%20amyloid%20cardiomyopathy%20patients:%20an%20analysis%20from%20the%20tafamidis%20in%20transthyretin%20cardiomyopathy%20clinical%20trial%20(ATTR-ACT)%20and%20the%20open-label%20long-term%20extension%20studies&amp;author=M.H.%20Rozenbaum&amp;author=A.%20Garcia&amp;author=D.%20Grima&amp;volume=8&amp;issue=5&amp;publication_year=2022&amp;pages=529-538&amp;pmid=33895806&amp;doi=10.1093/ehjqcco/qcab031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib32">
<span class="label">32.</span><cite>Vong C., Boucher M., Riley S., Harnisch L.O. Modeling of survival and frequency of cardiovascular-related hospitalization in patients with transthyretin amyloid cardiomyopathy treated with tafamidis. Am J Cardiovasc Drugs. 2021;21(5):535–543. doi: 10.1007/s40256-021-00464-y.</cite> [<a href="https://doi.org/10.1007/s40256-021-00464-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8435516/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33770392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cardiovasc%20Drugs&amp;title=Modeling%20of%20survival%20and%20frequency%20of%20cardiovascular-related%20hospitalization%20in%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy%20treated%20with%20tafamidis&amp;author=C.%20Vong&amp;author=M.%20Boucher&amp;author=S.%20Riley&amp;author=L.O.%20Harnisch&amp;volume=21&amp;issue=5&amp;publication_year=2021&amp;pages=535-543&amp;pmid=33770392&amp;doi=10.1007/s40256-021-00464-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib33">
<span class="label">33.</span><cite>Socie P., Benmalek A., Cauquil C., et al.  Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis. Amyloid. 2023:1–10. doi: 10.1080/13506129.2023.2177986.</cite> [<a href="https://doi.org/10.1080/13506129.2023.2177986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36795029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Comparison%20between%20tafamidis%20and%20liver%20transplantation%20as%20first-line%20therapy%20for%20hereditary%20transthyretin%20amyloidosis&amp;author=P.%20Socie&amp;author=A.%20Benmalek&amp;author=C.%20Cauquil&amp;publication_year=2023&amp;pages=1-10&amp;pmid=36795029&amp;doi=10.1080/13506129.2023.2177986&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib34">
<span class="label">34.</span><cite>Bhambri R., Colavecchia A.C., Bruno M., et al.  Real-world characteristics of patients with wild-type transthyretin amyloid cardiomyopathy: an analysis of electronic healthcare records in the United States. Am J Cardiovasc Drugs. 2023;23(2):197–206. doi: 10.1007/s40256-022-00563-4.</cite> [<a href="https://doi.org/10.1007/s40256-022-00563-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10006039/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36780092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Cardiovasc%20Drugs&amp;title=Real-world%20characteristics%20of%20patients%20with%20wild-type%20transthyretin%20amyloid%20cardiomyopathy:%20an%20analysis%20of%20electronic%20healthcare%20records%20in%20the%20United%20States&amp;author=R.%20Bhambri&amp;author=A.C.%20Colavecchia&amp;author=M.%20Bruno&amp;volume=23&amp;issue=2&amp;publication_year=2023&amp;pages=197-206&amp;pmid=36780092&amp;doi=10.1007/s40256-022-00563-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib35">
<span class="label">35.</span><cite>Razvi Y., Porcari A., Di Nora C., et al.  Cardiac transplantation in transthyretin amyloid cardiomyopathy: outcomes from three decades of tertiary center experience. Front Cardiovasc Med. 2023;9 doi: 10.3389/fcvm.2022.1075806.</cite> [<a href="https://doi.org/10.3389/fcvm.2022.1075806" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9894650/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36741843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Cardiovasc%20Med&amp;title=Cardiac%20transplantation%20in%20transthyretin%20amyloid%20cardiomyopathy:%20outcomes%20from%20three%20decades%20of%20tertiary%20center%20experience&amp;author=Y.%20Razvi&amp;author=A.%20Porcari&amp;author=C.%20Di%20Nora&amp;volume=9&amp;publication_year=2023&amp;pmid=36741843&amp;doi=10.3389/fcvm.2022.1075806&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib36">
<span class="label">36.</span><cite>Roy A., Peterson A., Marchant N., et al.  Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: a retrospective analysis of a Medicare cohort. J Manag Care Spec Pharm. 2022;28(7):766–777. doi: 10.18553/jmcp.2022.28.7.766.</cite> [<a href="https://doi.org/10.18553/jmcp.2022.28.7.766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10372989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35737856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Manag%20Care%20Spec%20Pharm&amp;title=Baseline%20characteristics%20and%C2%A0secondary%20medication%20adherence%20among%20Medicare%20patients%20diagnosed%20with%20transthyretin%20amyloid%20cardiomyopathy%20and/or%C2%A0receiving%20tafamidis%20prescriptions:%20a%20retrospective%20analysis%20of%20a%20Medicare%20cohort&amp;author=A.%20Roy&amp;author=A.%20Peterson&amp;author=N.%20Marchant&amp;volume=28&amp;issue=7&amp;publication_year=2022&amp;pages=766-777&amp;pmid=35737856&amp;doi=10.18553/jmcp.2022.28.7.766&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib37">
<span class="label">37.</span><cite>Antonopoulos A.S., Panagiotopoulos I., Kouroutzoglou A., et al.  Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta-analysis. Eur J Heart Fail. 2022;24(9):1677–1696. doi: 10.1002/ejhf.2589.</cite> [<a href="https://doi.org/10.1002/ejhf.2589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35730461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail&amp;title=Prevalence%20and%20clinical%20outcomes%20of%20transthyretin%20amyloidosis:%20a%20systematic%20review%20and%20meta-analysis&amp;author=A.S.%20Antonopoulos&amp;author=I.%20Panagiotopoulos&amp;author=A.%20Kouroutzoglou&amp;volume=24&amp;issue=9&amp;publication_year=2022&amp;pages=1677-1696&amp;pmid=35730461&amp;doi=10.1002/ejhf.2589&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib38">
<span class="label">38.</span><cite>Rettl R., Mann C., Duca F., et al.  Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2022;23(6):767–780. doi: 10.1093/ehjci/jeab226.</cite> [<a href="https://doi.org/10.1093/ehjci/jeab226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34788394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J%20Cardiovasc%20Imaging&amp;title=Tafamidis%20treatment%20delays%20structural%20and%20functional%20changes%20of%20the%20left%20ventricle%20in%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy&amp;author=R.%20Rettl&amp;author=C.%20Mann&amp;author=F.%20Duca&amp;volume=23&amp;issue=6&amp;publication_year=2022&amp;pages=767-780&amp;pmid=34788394&amp;doi=10.1093/ehjci/jeab226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplemental Material</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/10474377/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (324.4KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from eClinicalMedicine are provided here courtesy of <strong>Elsevier</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1016/j.eclinm.2023.102172"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/main.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (826.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/10474377/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/10474377/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC10474377%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC10474377/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC10474377/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC10474377/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/37662524/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC10474377/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/37662524/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC10474377/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/10474377/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="sZ7CT4H2hpTwx2zWEY1igmOMnv9oljOptIUjmP5eeL82RvShSc6Y40gm8jpYYTv3">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
